HER2-SADA (Y-mAbs Therapeutics)

N/A

Report date: 2025/11/14 09:32:45

Base Information

Drug NameHER2-SADA (Y-mAbs Therapeutics)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > AntibodyRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radionuclide Drug Conjugates
Mechanisms of ActionIonising radiation emitters
TargetsUpdating
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMassachusetts Institute Of TechnologyMemorial Sloan-Kettering Of Connecticut Inc
China Registration ClassN/A

Develop Information

Active CompaniesY-Mabs Therapeutics Inc
Inactive CompaniesMemorial Sloan-Kettering Of Connecticut IncMassachusetts Institute Of Technology
Active IndicationsN/A
Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A